Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
Jeffrey M. Riggs(AstraZeneca (Netherlands)), Roland Kolbeck(AstraZeneca (Australia))
Cited by 143
Related Papers
MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
|Journal of Allergy and Clinical Immunology|2010|578
IL-9 Governs Allergen-induced Mast Cell Numbers in the Lung and Chronic Remodeling of the Airways
|American Journal of Respiratory and Critical Care Medicine|2010|211
Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungs
|Molecular Therapy — Methods & Clinical Development|2023|11